1.25
price up icon1.63%   0.02
after-market Handel nachbörslich: 1.23 -0.02 -1.60%
loading
Schlusskurs vom Vortag:
$1.23
Offen:
$1.24
24-Stunden-Volumen:
34,616
Relative Volume:
0.19
Marktkapitalisierung:
$3.16M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.08M
KGV:
-0.1947
EPS:
-6.42
Netto-Cashflow:
$-11.56M
1W Leistung:
+0.81%
1M Leistung:
+1.63%
6M Leistung:
-78.63%
1J Leistung:
-84.91%
1-Tages-Spanne:
Value
$1.23
$1.26
1-Wochen-Bereich:
Value
$1.19
$1.32
52-Wochen-Spanne:
Value
$1.01
$11.55

Enveric Biosciences Inc Stock (ENVB) Company Profile

Name
Firmenname
Enveric Biosciences Inc
Name
Telefon
239-302-1707
Name
Adresse
4851 TAMIAMI TRAIL N, SUITE 200, NAPLES
Name
Mitarbeiter
6
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
ENVB's Discussions on Twitter

Vergleichen Sie ENVB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ENVB
Enveric Biosciences Inc
1.25 3.16M 0 -15.08M -11.56M -6.42
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Enveric Biosciences Inc Aktie (ENVB) Neueste Nachrichten

pulisher
Jun 16, 2025

Enveric Biosciences Announces Participation in 2025 BIO International Convention | ENVB Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Enveric Biosciences Announces Participation in 2025 BIO International Convention - Business Wire

Jun 16, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice Of Allowance For New Class Of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice of Allowance for New Class o - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences (ENVB) Gains Patent Approval for Innovative Compounds | ENVB Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders | ENVB Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders - Yahoo Finance

Jun 10, 2025
pulisher
Jun 04, 2025

Enveric Receives U.S. Patent for Sleep, CNS Therapeutics - Insider Monkey

Jun 04, 2025
pulisher
Jun 03, 2025

Enveric’s Patent Win Targets New Frontiers in Sleep Medicine - microdose.buzz

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences (ENVB) Secures Patent for Novel CNS Therapeu - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Receives New US Patent on Molecules for Central Nervous System, Sleep Therapeutics - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences secures patent for sleep disorder molecules By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences (ENVB) Secures Patent for Novel CNS Therapeutic Compounds | ENVB Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Announces Issuance of U.S. Patent Covering a - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds | ENVB Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds - Yahoo Finance

Jun 03, 2025
pulisher
May 29, 2025

Enveric Biosciences announces results from EB-003 trial - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Enveric’s EB-003 shows statistically significant improvements in model of severe chronic depression - BioWorld MedTech

May 29, 2025
pulisher
May 28, 2025

Enveric Biosciences Reports Positive Preclinical Results For Lead Drug Candidate EB-003 - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences reports breakthrough in depression model By Investing.com - Investing.com India

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences (ENVB) Reports Promising Preclinical Results - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences reports breakthrough in depression model - Investing.com Australia

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences (ENVB) Reports Promising Preclinical Results for EB-003 | ENVB Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003 | ENVB Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003 - Business Wire

May 28, 2025
pulisher
May 28, 2025

Enveric Biosciences (NASDAQ:ENVB) Stock Price Down 0.8% – Here’s Why - Defense World

May 28, 2025
pulisher
May 20, 2025

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences Stakes Its Claim in Neurodegeneration Market - microdose.buzz

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences files provisional patent for new molecules By Investing.com - Investing.com Canada

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences Identifies Neuroplastogen Candidates with Po - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences (ENVB) Explores New Path with Neurodegenerative Drug Patent | ENVB Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Enveric Biosciences files new provisional patent application - TipRanks

May 20, 2025
pulisher
May 14, 2025

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results - BioSpace

May 14, 2025
pulisher
May 14, 2025

Enveric Biosciences Reports First Quarter 2025 Financial and Cor - GuruFocus

May 14, 2025
pulisher
May 11, 2025

Enveric Biosciences (ENVB) Projected to Post Earnings on Tuesday - Defense World

May 11, 2025
pulisher
Apr 30, 2025

Enveric Biosciences stock plummets after pricing $5M capital raise - MSN

Apr 30, 2025
pulisher
Apr 17, 2025

Enveric Biosciences (NASDAQ:ENVB) Trading Down 1% – Here’s Why - Defense World

Apr 17, 2025
pulisher
Apr 15, 2025

Enveric Biosciences appoints new accounting firm - Investing.com India

Apr 15, 2025
pulisher
Apr 14, 2025

Enveric Biosciences appoints new accounting firm By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 05, 2025

ENVB Stock Touches 52-Week Low at $1.12 Amid Market Challenges - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

ENVB Stock Touches 52-Week Low at $1.12 Amid Market Challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 03, 2025

Psychedelic: Enveric, Filament Health report earnings results - TipRanks

Apr 03, 2025
pulisher
Apr 01, 2025

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024 - BioSpace

Apr 01, 2025
pulisher
Mar 31, 2025

Enveric posts $9.5M loss for 2024, but revenue could be on horizon with licensing deals - Green Market Report

Mar 31, 2025
pulisher
Mar 31, 2025

Enveric Lands Massive $184M Biotech Licensing Deals as EB-003 Shows Promise - Stock Titan

Mar 31, 2025
pulisher
Mar 28, 2025

Enveric Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Enveric Biosciences, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Enveric Biosciences Inc. (ENVB) reports earnings - qz.com

Mar 28, 2025
pulisher
Mar 21, 2025

Enveric Biosciences Inc expected to post a loss of 23 cents a shareEarnings Preview - TradingView

Mar 21, 2025
pulisher
Mar 18, 2025

Enveric Biosciences Announces 1-for-15 Reverse Stock Split - MSN

Mar 18, 2025

Finanzdaten der Enveric Biosciences Inc-Aktie (ENVB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):